about
Genetic and epigenetic control of metabolic healthDiabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Non-referenced genome assembly from epigenomic short-read dataGenome-wide DNA methylation analysis reveals hypomethylation in the low-CpG promoter regions in lymphoblastoid cell linesType 2 diabetes and cardiovascular disease: Have all risk factors the same strength?Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes.The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.Introduction to personalized medicine in diabetes mellitus.The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction.Glycemic memories and the epigenetic component of diabetic nephropathy.Epigenetic regulation of pancreatic islets.Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Epigenetic dysfunctional diseases and therapy for infection and inflammation.Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.Epigenetic alterations in patients with type 2 diabetes mellitusElevation of PTPN1 promoter methylation is a significant risk factor of type 2 diabetes in the Chinese populationAttenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.LncRNAs: Proverbial Genomic "Junk" or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?Differential Response of Human Hepatocyte Chromatin to HDAC Inhibitors as a Function of Microenvironmental Glucose Level.Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.
P2860
Q27026287-9F7585F0-97B3-4CA3-BA61-8B061176FB52Q28072462-8C3F191C-BC97-4107-97F3-F2804BD2D0EFQ28079163-387C24DA-D07E-4F8D-A851-72C907339C5AQ30597265-0EFA010E-3E80-4AC0-8D5E-7B13D0E25ED0Q30872605-75146080-AA96-4779-A094-5462652CACA1Q33677144-178A0727-BFC8-48A4-9CA2-2BD1306EFDD6Q34023548-757C8A65-E04F-4136-B5CB-445B81BC3ED7Q35645997-869C4DA0-A232-4F8E-9251-9BBDC4E16227Q37247435-4CA03951-AEFD-4D1F-8103-D9A7812C8348Q37523745-BD43BC42-FD14-4F98-BA4E-5E35656A9C85Q37679215-25CD9DA1-0A85-48B8-BA60-1A5A5018FB3CQ38103744-849A60D6-ADF7-428B-A747-DDBF57792BABQ38125919-5A85A7DB-1D13-456C-B61D-965AEEEFE424Q38297582-4058D997-AF5A-4AEF-91CF-601EA7E71B2AQ38537772-85848AFA-8625-4C9C-A61D-D830F28DF99BQ38537774-D059B447-4160-423B-8620-3E03620D7986Q38833038-1C29888F-8F41-4E3F-BD7C-898E960034AFQ39029869-A8EDFC46-F054-46D3-9902-737823693D8FQ39069908-3B2F0954-C837-4B36-9BD8-3AD0A72E0A4FQ41110363-35E9C915-A4DF-42CD-96EE-D57BA7156A11Q42376412-327B175E-89C0-4918-812B-93AD2639CBE9Q48264108-53505674-5070-4B38-A869-D9A696C7A97AQ51743274-C222A2D0-FCEC-4E41-9A85-0694D33125B5Q52578935-0DDD6928-7180-4707-BD6D-2435549D150AQ52884352-F511CF6B-4D04-462A-A468-C948B9C9B22CQ55234298-0588F938-FDFB-403E-841E-84413BD1B8E4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic changes in diabetes.
@en
type
label
Epigenetic changes in diabetes.
@en
prefLabel
Epigenetic changes in diabetes.
@en
P2860
P50
P356
P1433
P1476
Epigenetic changes in diabetes
@en
P2093
S T Keating
P2860
P356
10.1111/CGE.12121
P577
2013-03-11T00:00:00Z